Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy
Abstract Context Toxicity-monitoring plays an important role in all cancer treatment, however, early recognition is vital for detecting and treating immune-related symptoms. Preparing a Patient Reported Outcomes tool and including melanoma patients receiving immunotherapy in the reporting of symptom...
Saved in:
Main Authors: | Lærke K. Tolstrup (Author), Lars Bastholt (Author), Ann-Dorthe Zwisler (Author), Karin B. Dieperink (Author), Helle Pappot (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial
by: Lærke K. Tolstrup, et al.
Published: (2020) -
Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial
by: Lærke K. Tolstrup, et al.
Published: (2022) -
Chronic granulomatous reaction in patients receiving vaccine immunotherapy for metastatic melanoma
by: Alexander B. Aria, BS, et al.
Published: (2018) -
Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy
by: Howa Yeung, et al.
Published: (2023) -
Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy
by: Gry Assam Taarnhøj, et al.
Published: (2019)